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Review
The prevalence of type 2 diabetes (T2D) is 
increasing rapidly worldwide, and this disease 
has posed an enormous public health chal­
lenge. It is widely considered that complex 
interactions between genetic and environmen­
tal factors may underlie the etiology of diabetes 
(Hu 2011). Growing evidence has recently 
linked risk of T2D with some environmental 
pollutants, such as persistent organic pollutants 
(POPs) (Everett et al. 2010).
POPs are a variety of synthetic compounds 
that can accumulate in human adipose tis­
sue and are characterized by slow degrada­
tion (Milbrath et al. 2009). Common types 
of POPs include polychlorinated biphenyls 
(PCBs) and organochlorine pesticides such 
as dichlorodiphenyltrichloroethane (DDT) 
and its major metabolite, dichlorodiphenyl­
dichloro ethylene (DDE), and hexachloro­
benzene (HCB). Contaminated fish, meat, 
and dairy food products are the primary 
sources of exposure in the general popula­
tion (Milbrath et al. 2009). In addition, 
inhalation from indoor air and ingestion of 
dust have been suggested to be other impor­
tant sources of PCB exposure (Harrad et al. 
2009). Although the use of PCBs and DDT 
was banned decades ago, serum concentra­
tions of these pollutants are still detectable 
in most of the U.S. population (Lee et al. 
2007a). Animal studies have suggested that 
exposure to POPs may induce abdominal obe­
sity, impair insulin sensitivity (Ruzzin et al. 
2010), and reduce glucose uptake (Enan and 
Matsumura 1994). Several cross­sectional 
studies have reported that certain POPs were 
significantly associated with T2D (Airaksinen 
et al. 2011; Codru et al. 2007; Lee et al. 2006; 
Philibert et al. 2009; Rignell­Hydbom et al. 
2007; Rylander et al. 2005). Overall, limited 
prospective data also suggest that exposure to 
POPs may increase the risk of T2D (Lee et al. 
2010, 2011; Rignell­Hydbom et al. 2009; 
Turyk et al. 2009; Vasiliu et al. 2006; Wang 
et al. 2008); however, associations of individ­
ual POPs were not entirely consistent across 
the studies. For example, total PCBs were 
associated with risk of diabetes in some (Lee 
et al. 2011; Vasiliu et al. 2006), but not all 
studies (Turyk et al. 2009; Wang et al. 2008). 
Moreover, evidence for DDT/DDE (Audouze 
and Grandjean 2011; Lee et al. 2010) and 
HCB (Lee et al. 2010, 2011) is sparse. Small 
sample sizes, different exposure distributions, 
and other characteristics of study populations 
may potentially explain the inconsistency. 
In the present study, we aimed to prospec­
tively evaluate plasma concentrations of PCB 
congeners, DDT, DDE, and HCB in relation 
to risk of T2D using existing data from the 
Nurses’ Health Study (NHS). We also con­
ducted a meta­analysis to summarize existing 
prospective evidence on relevant associations.
Methods
Study population. The NHS is an ongoing pro­
spective cohort of 121,700 female registered 
nurses who were 30 to 55 years old at study 
inception in 1976 when each nurse completed 
a mailed questionnaire about her medical his­
tory and lifestyle (Colditz et al. 1997). A total 
of 32,826 women provided blood samples in 
1989 and 1990. Among these participants, 
multiple nested case– control studies were con­
ducted to evaluate biomarkers and disease risk 
using the same design: For each disease out­
come, incident cases were identified/confirmed 
among disease­free participants and matched 
controls were randomly selected using risk­set 
sampling. Participants for the present analy­
ses were initially selected for two independent 
nested case– control studies: a non­Hodgkin 
lymphoma (NHL) study (Laden et al. 2010) 
and a breast cancer study (Laden et al. 2001). 
A total of 145 NHL cases (diagnosed before 
2004) and 2 controls per case (n = 290) in the 
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Background: Prospective data regarding persistent organic pollutants (POPs) and risk of type 2 
 diabetes (T2D) are limited, and the results for individual POPs are not entirely consistent across 
studies.
oBjectives: We prospectively examined plasma POP concentrations in relation to incident T2D 
and summarized existing evidence in a meta-analysis.
Methods: Plasma polychlorinated biphenyls (PCBs), dichlorodiphenyltrichloroethane (DDT), 
dichlorodiphenyldichloroethylene (DDE), and hexachlorobenzene (HCB) concentrations were mea-
sured in 1,095 women who were free of diabetes at blood draw in 1989–1990 and participated in 
two case–control studies in the Nurses’ Health Study. We identified 48 incident T2D cases through 
30 June 2008. We conducted a literature search in PubMed and EMBASE through December 2011 
to identify prospective studies on POPs in relation to diabetes. We used a fixed-effects model to 
summarize results.
results: After multivariable adjustment, plasma HCB concentration was positively associated with 
incident T2D [pooled odds ratio (OR) 3.59 (95% CI: 1.49, 8.64, ptrend = 0.003) comparing extreme 
tertiles]. Other POPs were not significantly associated with diabetes. After pooling our results with 
those of six published prospective studies that included 842 diabetes cases in total, we found that 
HCB and total PCBs both were associated with diabetes: the pooled ORs were 2.00 (95% CI: 
1.13, 3.53; I 2 = 21.4%, pheterogeneity = 0.28) and 1.70 (95% CI: 1.28, 2.27; I 2 = 16.3%, pheterogeneity 
= 0.30) for HCB and total PCBs, respectively. 
conclusions: These findings support an association between POP exposure and the risk of T2D.
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NHL study (Laden et al. 2010), and 381 pairs 
of breast cancer cases (diagnosed before 1994) 
and controls in the breast cancer study (Laden 
et al. 2001) were included. Measurements of 
plasma POPs and lipid concentrations before 
cancer diagnosis were available for 435 nurses 
from the NHL study and 744 nurses from 
the breast cancer study. These participants 
constituted the study population for the 
present analysis.
The study protocol was approved by the 
institutional review board of the Brigham and 
Women’s Hospital and the Human Subjects 
Committee Review Board of Harvard School 
of Public Health. All participants provided 
written informed consent.
Ascertainment of T2D. The study outcome 
in the present investigation was incident T2D 
diagnosed between the baseline blood draw in 
1989–1990 and 30 June 2008. We sent a vali­
dated supplementary questionnaire (Manson 
et al. 1991) to participants who reported having 
diabetes in follow­up questionnaires to confirm 
the diagnosis of diabetes. In this supple mentary 
questionnaire, we collected information on 
symptoms, diagnostic tests, and treatment. 
Over the years, the response rate to this supple­
mentary questionnaire has approached 100%. 
For self­reported cases before 1998, we used 
the National Diabetes Data Group criteria 
(National Diabetes Data Group 1979) to con­
firm diagnosis of T2D. Since 1998, we have 
applied the American Diabetes Association cri­
teria (American Diabetes Association 1997) to 
confirm the cases. The validity of the supple­
mentary questionnaire for confirming the diag­
nosis of diabetes has been described previously 
(Manson et al. 1991). Of a random sample of 
62 women reporting T2D in the supplemen­
tary questionnaire, the diagnosis was confirmed 
in 61 (98%) of them after their medical records 
were reviewed by an endocrinologist blinded to 
the supplementary questionnaire information 
(Manson et al. 1991). 
Exclusions. We examined the diabetes 
diagnosis status among the 1,179 participants 
from the NHL and breast cancer studies. 
We excluded 81 participants who developed 
diabetes before blood draw. In addition, we 
excluded 3 participants who had missing POP 
data. After these exclusions, a total of 1,095 
participants who were free of diabetes at blood 
collection were included in the analysis. Of 
these participants, we identified 48 incident 
T2D cases through June 2008. The remaining 
1,047 nondiabetic participants served as popu­
lation controls. 
Laboratory analyses of POPs. The meth­
ods for measuring POP concentrations were 
described in detail in previous publications 
(Laden et al. 2001, 2010). In the present 
study, we focused on the four most abundant 
PCB congeners (118, 138, 153, and 180), 
p,p´­DDT, p,p´­DDE, and HCB. A total of 
18 minor PCB congeners in the breast cancer 
study and 52 minor PCB congeners in the 
NHL study were measured as well, and their 
original concentrations were summed with the 
concentrations of the four major PCBs to cal­
culate the total PCB concentration. Total POP 
concentrations were calculated by summing 
concentrations of total PCBs, DDT, DDE, 
and HCB. We also examined the associations 
for total PCBs and total POPs in each study. 
Of note, there were some important dif­
ferences in laboratory methods between the 
two contributing studies. For the breast cancer 
study, laboratory assays were performed at the 
Mount Sinai School of Medicine (New York, 
NY, USA) in 1994–1997 by single­column 
gas chromatography with electron capture 
detection (Laden et al. 2001). The limits of 
detection (LODs) were < 1 ng/mL for HCB, 
DDT, DDE, and PCBs. The detection rate 
was 95.2% for HCB, 98.3% for DDT, 99.8% 
for DDE, and > 99.4% for PCB congeners 
118, 138, 153, and 180. The median coef­
ficients of variation (CVs) in the breast cancer 
study were 5.0% for DDE, 12.0% for total 
PCBs, and 8.1–12.4% for the four main PCB 
congeners (Laden et al. 2001). In contrast, for 
the NHL study, laboratory assays were per­
formed at the Harvard School of Public Health 
in 2004–2005 using dual capillary column gas 
chromatography to separate interfering peaks 
(Bertrand et al. 2010; Laden et al. 2010). The 
LODs ranged from 0.007 ng/mL for HCB 
to 0.039 ng/mL for PCB­180. The detection 
rate was 100% for HCB and DDE, 96.5% for 
DDT, and > 99.4% for the four major PCBs. 
Any value below LOD for a given pollutant 
was set to be the detection limit of that pollut­
ant to preserve statistical power. The median 
CVs of measurement in the NHL study were 
< 7.5% for all POPs of interest. 
We found reasonable correlations between 
POP concentrations in 30 samples that were 
assayed using both methods. The Spearman 
correlation coefficients were 0.53 for PCB­118, 
0.60 for PCB­138, 0.75 for PCB­153, 0.77 for 
PCB­180, 0.76 for HCB, 0.92 for DDE (all 
p­values < 0.01), and 0.10 for DDT (p = 0.59). 
The two data sets were analyzed separately, as 
described below. 
Assessment of covariates. Information 
about current body weight, lifestyle factors, 
and family history of diabetes was derived 
from the 1990 follow­up question naire 
(Colditz et al. 1997). Body mass index (BMI) 
was calculated as weight in kilograms divided 
by height in meters squared. Physical activ­
ity was expressed as metabolic equivalent task 
(MET) in hours per week. The validity of the 
self­reported body weight and physical activity 
levels has been described previously (Rimm 
et al. 1990; Wolf et al. 1994). 
Statistical analyses. Because POPs are 
highly lipophilic and, therefore, predominantly 
carried by blood lipids, lipid­ standardized POP 
concentrations [nanograms per gram of plasma 
total lipids derived using the Phillips formula 
(Phillips et al. 1989)] were used in the present 
analysis to minimize the impact of blood lipids 
on the associations of interest. We used logistic 
regression to estimate odds ratios (ORs) and 
95% CIs of incident T2D risk by tertiles of 
POP concentrations that were defined sepa­
rately for each study. In multivariable analy­
sis, we adjusted for potential confounders, 
including age (years), smoking status (never, 
current smoker, past smoker), alcohol intake 
(0, 0.1–10, and > 10 g/day), physical activ­
ity (MET­hr/week), family history of diabetes 
(yes/no), and BMI at baseline, as well as cancer 
case– control status. To test for linear trend, we 
modeled the median concentrations of POP 
tertiles as a continuous variable. Natural log 
transformation of POP concentrations was 
applied to model linear associations between 
POP exposures and diabetes risk. Because 
of the apparent between­assay differences in 
POP assay methodology, we performed the 
above­mentioned analyses within each study 
separately and then pooled results using a fixed­
effects model. To derive pooled p­values for 
trend, we pooled regression coefficients for the 
median concentrations of POP tertiles using a 
fixed­effects model and then estimated p­values 
for the pooled regression coefficients. 
Sensitivity analysis. Because POP exposures 
were associated with elevated triglyceride con­
centrations (Lee et al. 2007b) and dyslipidemia 
is associated with T2D status (Mooradian 
2009), the use of lipid­ standardized POP con­
centrations may cause bias (Schisterman et al. 
2005). Therefore, we also examined plasma 
weight­adjusted POP concentrations in rela­
tion to risk of T2D and controlled for plasma 
total cholesterol and triglycerides as covariates 
in multivariable models. Because there were 
no T2D cases in the lowest HCB tertile, when 
analyzing data for HCB, we categorized the 
study population using the following cutoff 
points: ≤ median, median to 75th percentile, 
and ≥ 75th percentile. In another sensitivity 
analysis, we used a nonparametric approach 
(Rosner and Glynn 2007) to derive a stan­
dardized score for each POP within each study 
to account for the differences in POP assays 
between studies. Briefly, within each data set, 
we transformed the POP concentrations to 
a probit scale to normalize the distribution, 
and then ranked the data to generate study­
specific tertiles. We then pooled individual­
 level data from both studies and repeated the 
analysis. In addition, we conducted two sepa­
rate sensitivity analyses to evaluate the possible 
impact of cancer treatment on the relationship. 
In the first analysis, we restricted our analysis 
to participants who did not develop cancer 
by the end of follow­up. In the second analy­
sis, we excluded diabetes cases who reported 
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occurrence of cancer prior to diabetes diagnosis 
(n = 5). To examine whether the associations 
could be due to reverse causation bias, in a 
further sensitivity analysis we excluded diabetes 
cases reported ≤ 2 years after blood sample 
 collection in 1989–1990. 
Statistical analyses were performed using 
SAS version 9.1 (SAS Institute Inc., Cary, NC, 
USA). All reported p­values are two­sided, and 
α = 0.05 was used as the significance level.
Meta-analysis. Study selection. We 
searched the National Institutes of Health 
U.S. National Library of Medicine’s PubMed 
(http://www.ncbi.nlm.nih.gov/pubmed/) and 
Elsevier’s EMBASE (http://www.embase.com/) 
databases for articles regarding POP exposures 
and diabetes risk that were published through 
2 December 2011. [For a list of the search 
terms used, see Supplemental Material, p. 2 
(http://dx.doi.org/10.1289/ehp.1205248).] 
We applied the following study inclusion cri­
teria: a) a prospective study design, and b) that 
point estimates of relative risk (RR) of diabetes 
with 95% CI or SEs were available or could be 
derived. We excluded animal studies, clinical 
trials, cross­sectional studies, reviews, commen­
taries, letters, and studies that examined irrele­
vant exposures or outcomes. Two investigators 
(H.W. and K.A.B.) independently screened 
all studies by title or abstract, and then by a 
full text evaluation. Any discrepancy between 
the two authors was solved by discussion with 
the senior investigator (Q.S.). Of 589 unique 
publications identified in the literature search, 
we identified six prospective studies (Lee et al. 
2010, 2011; Rignell­Hydbom et al. 2009; 
Turyk et al. 2009; Vasiliu et al. 2006; Wang 
et al. 2008) that explicitly evaluated the associ­
ation between circulating POP concentrations 
and incident T2D (Figure 1).
Data extraction. We extracted the follow­
ing information from each study: study char­
acteristics (study name, authors, publication 
year, study design, duration of follow­up, and 
number of participants and incident cases), 
participant characteristics (age and sex), expo­
sure (POP concentrations for each category) 
and measurement method of POPs, outcome 
ascertainment, and analysis strategy (compari­
son categories, risk estimates for the compari­
son categories, and covariates included in the 
fully adjusted models). Data extraction was 
conducted independently by two investigators 
(H.W. and K.A.B.), and any discrepancy was 
again solved by discussion with Q.S. 
Statistical analyses. Meta­analyses were 
performed using Stata version 10.0 (StataCorp, 
College Station, TX, USA). We used a fixed­
 effects model to summarize study estimates 
comparing extreme categories (highest category 
vs. reference category) of POPs in each indi­
vidual study. In this analysis, we used loga­
rithms of RRs and corresponding SEs that were 
derived from the 95% CIs in each individual 
study. We also used a  random­effects model 
to pool RRs across studies. Hetero geneity 
among the results of these studies was evalu­
ated using the I2 statistic. We further used the 
meta­ regression approach (Stata METAREG 
command) to evaluate whether the associa­
tions of POPs were influenced by some study 
characteristics such as age, sex, demographic 
variables, baseline POP concentrations, diabe­
tes diagnosis strategies, duration of follow­up, 
and whether blood lipid was adjusted for in 
the final model. We also conducted a dose– 
response meta­ analysis by using the general­
ized least­squares method for trend estimation 
of summarized dose– response data (Stata 
GLST command) (Greenland and Longnecker 
1992). To evaluate a potential nonlinear dose– 
response relationship, we fitted two models: a 
restricted cubic spline regression model (Stata 
RC_SPLINE command) with four knots to 
create spline variables, and a linear regression 
model. We then examined the significance of 
nonlinear terms using the likelihood ratio test 
based on the statistics derived from these two 
models (Hu et al. 2012). To be consistent with 
previous studies, in this dose– response meta­
 analysis we used estimates that were based on 
plasma weight–adjusted POP concentrations. 
In addition, we excluded the Yucheng cohort 
(Wang et al. 2008) from the dose– response 
analysis because it included subjects who were 
poisoned by exposure to high levels of PCBs 
and polychlorinated dibenzofurans (PCDFs) in 
contaminated cooking oil (Guo et al. 1997).
Results
NHS. Table 1 shows the baseline charac­
teristics of participants in the two nested case– 
control studies. As expected, T2D patients 
had a significantly higher BMI at baseline 
and were more likely to have a family his­
tory of diabetes than were nondiabetic par­
ticipants in both studies. We did not observe 
statistically significant differences in plasma 
POP concentrations between diabetes cases 
and nondiabetic participants in either study. 
The baseline characteristics of participants 
by cancer case–control status are shown in 
Supplemental Material, Table S1 (http://
dx.doi.org/10.1289/ehp.1205248). The inci­
dent rate of T2D (cases/1,000 person­years) 
was significantly higher among cancer controls 
than cancer cases [3.63 vs. 0.57, p < 0.001 
in the breast cancer study and 4.52 vs. 0.99, 
p = 0.005 in the NHL study (see Supplemental 
Material, Table S1)], probably because cancer 
cases had higher mortality than controls (see 
Supplemental Material, Table S1).
We examined age­adjusted Spearman 
correla tions among plasma POPs, as well 
Figure 1. Literature search and study selection.
Literature search in
PubMed by 2 December 2011 
(n = 369)  
Literature search in
EMBASE by 2 December 2011
(n = 358) 
Abstracts reviewed
 (n = 589)  
Articles retrieved and reviewed
 (n = 10)  
Abstracts excluded:
Reviews, editorials, commentaries, and 
case reports (n = 109) 
Cross-sectional studies, retrospective studies, 
and clinical trials (n = 33)
Animal studies and human in vitro or in vivo 
studies (n = 181)
Irrelevant exposures or outcomes (n = 256)
Duplicate records removed (n = 138)
Study included (n = 6)
Studies excluded:
Exposure data were exposed days derived 
from questionnaire (n = 1)
Outcome was type 1 diabetes (n = 1)
Outcome was diabetes mortality (n = 2)     
Estimates included in the
meta-analysis (n = 8)
Current analysis (n = 2)
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as between baseline BMI and POPs [see 
Supplemental Material, Table S2 (http://
dx.doi.org/10.1289/ehp.1205248)]. The four 
major PCB congeners were highly correlated 
with each other in both studies, and all of the 
pairwise correlation coefficients were > 0.53. 
Positive associations were also observed among 
DDT, DDE, and HCB, although the cor­
relations were somewhat weaker in the breast 
cancer study than in the NHL study. In gen­
eral, BMI at baseline was inversely correlated 
with PCBs in both studies, except PCB­118 in 
the NHL study for which the correlation was 
positive (rS = 0.17). The correlations between 
BMI and DDT, DDE, and HCB were very 
weak (|rS| < 0.10), with the exception of the 
correlation between BMI and DDT in the 
NHL study (rS = 0.20).
Table 2 shows the association between 
plasma POP concentrations and diabetes in 
each study. Overall, patterns of associations 
were similar between the two studies. Of the 
POPs evaluated, HCB showed the strongest 
association with T2D. In the multivariable 
analysis adjusted for age, BMI, and other cova­
riates (model 1), the ORs of T2D comparing 
extreme tertiles were 3.73 (95% CI: 1.05, 13.3; 
ptrend = 0.04) in the breast cancer study, and 
3.46 (95% CI: 1.02, 11.7; ptrend = 0.03) in the 
NHL study. The pooled OR based on a fixed­
effects model was 3.59 (95% CI: 1.49, 8.64; 
ptrend = 0.003) comparing extreme tertiles 
(Table 3, model 1). Further adjustment of 
NHL and breast cancer case– control status 
(Tables 2 and 3, model 2) did not materially 
change the study­specific or pooled results. 
When we modeled the association between 
natural log­transformed plasma POP concen­
trations and T2D risk, we estimated that per 
SD increment of HCB was associated with a 
pooled OR of 2.38 (95% CI: 1.03, 5.48, 
p = 0.04) in multivariable adjustment model 
[see Supplemental Material, Table S3, model 1 
(http://dx.doi.org/10.1289/ehp.1205248)]. In 
pooled analysis, total PCBs, total concentrations 
of the four major PCB congeners (∑PCBs), and 
other individual POPs, except PCB­138, were 
also associated with a non significantly increased 
T2D risk. Total POPs, which were the sum of 
total PCBs, DDT, DDE, and HCB, showed 
non significantly posi tive association with risk 
of T2D: The multi variable­adjusted (Table 2, 
model 1) ORs were 1.95 (95% CI: 0.62, 6.16; 
ptrend = 0.27) and 1.50 (95% CI: 0.49, 4.64; 
ptrend = 0.50) comparing extreme tertiles in the 
breast cancer study and the NHL study, respec­
tively. The pooled OR was 1.71 (95% CI: 
0.76, 3.82; ptrend = 0.22) comparing the highest 
to the lowest tertile (Table 3, model 1).
Sensitivity analysis. We observed similar 
associations when modeling plasma weight­
adjusted POPs and adjusting for plasma 
total cholesterol and triglycerides as covari­
ates in multivariable models [see Supplemental 
Material, Tables S4 and S5 (http://dx.doi.
org/10.1289/ehp.1205248)]. HCB still 
showed the strongest association with risk of 
T2D. The pooled OR was 3.76 (95% CI: 
1.50, 9.44; ptrend = 0.005) comparing extreme 
tertiles. Other POPs did not show significant 
association with diabetes based on this analy­
sis. When we used a nonparametric approach 
to derive a standardized score to account 
for the between­study differences, we again 
found similar associations (see Supplemental 
Material, Table S6). For example, in compari­
son to women in the lowest HCB score ter­
tile, women in the highest tertile had an OR 
of 3.79 (95% CI: 1.54, 9.34; ptrend = 0.003), 
and other POPs were not significantly associ­
ated with diabetes. We observed largely similar 
results among cancer­free participants based on 
pooled fixed­effects estimates (see Supplemental 
Material, Table S7). After excluding T2D cases 
that occurred ≤ 2 years after blood collection 
(n = 7) or T2D cases that had any prior cancer 
diagnosis (n = 5), multivariable­adjusted ORs 
for the highest versus lowest tertiles of HCB 
were 3.91 (95% CI: 1.46, 10.5) and 3.03 
(95% CI: 1.26, 7.28), respectively. Estimates 
for other POPs were also comparable to those 
for the main analysis (data not shown). 
Meta-analysis. The characteristics of the 
six published prospective studies that evalu­
ated circulating POP concentrations in rela­
tion to incident diabetes are shown in Table 4. 
Most studies included both men and women, 
except one study (Rignell­Hydbom et al. 
2009) that included women only. Three stud­
ies reported associations for men and women 
separately (Turyk et al. 2009; Vasiliu et al. 
2006; Wang et al. 2008). The specific POPs 
investigated varied across these studies: Four 
studies examined total PCBs (Lee et al. 2011; 
Turyk et al. 2009; Vasiliu et al. 2006; Wang 
et al. 2008), four studies examined DDE (Lee 
et al. 2010, 2011; Rignell­Hydbom et al. 
2009; Turyk et al. 2009), three studies evalu­
ated PCB­118 and PCB­153 independently 
(Lee et al. 2010, 2011; Turyk et al. 2009), 
two studies assessed PCB­180 and HCB (Lee 
Table 1. Characteristics of NHS study participants at baseline in 1990.
Breast cancer study NHL study
Variable Diabetic (n = 24) Nondiabetic (n = 649) Diabetic (n = 24) Nondiabetic (n = 398)
Age (years) 58.0 ± 6.3 58.6 ± 6.8 59.6 ± 5.7 58.7 ± 6.5
BMI (kg/m2) 30.1 ± 6.4 24.7 ± 4.1 27.6 ± 5.6 24.9 ± 4.1
Smoking status [n (%)]
Never smoked 11 (45.8) 297 (45.8) 13 (54.2) 178 (44.7)
Past smoker 11 (45.8) 276 (42.5) 6 (25.0) 177 (44.5)
Current smoker 2 (8.4) 76 (11.7) 5 (20.8) 43 (10.8)
Alcohol drinking, g/day [n (%)]
0 8 (33.3) 113 (17.4) 8 (33.3) 104 (26.1)
0.1–10 13 (54.2) 361 (55.6) 15 (62.5) 208 (52.3)
> 10 3 (12.5) 175 (27.0) 1 (4.2) 86 (21.6)
Physical activity (MET-hr/week) 18.3 ± 20.6 17.6 ± 16.4 15.0 ± 12.9 18.7 ± 34.3
Family history of diabetes [n (%)] 9 (37.5) 153 (23.6) 14 (58.3) 108 (27.1)
PCB-118 (ng/g lipid)a 69.1 (54.8–107.6) 65.7 (46.6–85.6) 61.0 (43.3–79.0) 47.8 (34.2–73.4)
PCB-138 (ng/g lipid)a 95.9 (67.5–132.0) 94.4 (69.7–131.1) 58.3 (50.6–89.1) 64.1 (44.9–87.0)
PCB-153 (ng/g lipid)a 116.7 (79.5–161.7) 104.0 (80.8–141.6) 98.3 (82.0–123.7) 107.3 (78.6–139.0)
PCB-180 (ng/g lipid)a 71.3 (51.5–93.6) 74.6 (56.6–97.6) 65.7 (54.5–83.6) 71.8 (55.2–90.1)
∑PCBs (118,138,153,180) (ng/g lipid)a 365.2 (249.5–506.8) 346.0 (265.9–449.6) 291.8 (249.4–357.0) 300.7 (219.1–384.7)
Total PCBs (ng/g lipid)b 721.0 (604.5–1031.7) 742.8 (572.1–949.0) 628.2 (494.8–729.5) 621.7 (465.8–783.3)
p,p´-DDT (ng/g lipid)a 51.3 (37.6–114.6) 53.5 (32.5–94.9) 54.8 (31.4–76.2) 43.5 (28.1–67.3)
p,p´-DDE (ng/g lipid)a 826.5 (490.8–1435.2) 773.0 (453.3–1215.6) 1206.5 (817.9–1936.5) 973.8 (569.9–1717.8)
HCB (ng/g lipid)a 34.1 (27.0–43.3) 29.5 (22.0–39.0) 41.6 (33.3–47.7) 36.7 (30.0–45.5)
Total plasma cholesterol (mg/dL) 235.3 (193.8–265.1) 227.3 (200.2–253.0) 237.0 (182.5–282.0) 219.0 (190.0–243.0)
Plasma triglycerides (mg/dL) 184.5 (115.0–248.0) 103.0 (71.0–154.0) 194.5 (145.0–242.5) 110.5 (76.0–161.0)
Data are means ± SDs or medians (inter quartile ranges) for continuous variables and n (%) for categorical variables. 
aAll POPs were adjusted for total plasma lipids derived using the Phillips formula: total plasma lipid = (2.27 × total plasma cholesterol) + plasma triglycerides + 0.623. bTotal PCBs were 
summed values of 22 PCB congeners in the breast cancer study and 56 PCB congeners in the NHL study.
Persistent organic pollutants and diabetes
Environmental Health Perspectives • volume 121 | number 2 | February 2013 157
et al. 2010, 2011), and only one study exam­
ined PCB­138 (Lee et al. 2011) or DDT (Lee 
et al. 2010). Most of these studies used logistic 
regression to examine the association between 
POPs and incident diabetes (Lee et al. 2010, 
2011; Rignell­Hydbom et al. 2009; Wang 
et al. 2008), except that Turyk et al. (2009) 
used Cox regression and Vasiliu et al. (2006) 
used Poisson regression. The number of inci­
dent diabetes cases ranged from 36 to 371 
among these studies. In total, including our 
study, there were 842 diabetes cases. 
When all data were pooled using a fixed­
effects model, high concentrations of total 
PCBs and HCB were significantly associated 
with risk of diabetes, and the test for hetero­
geneity was not significant (Figure 2). The 
pooled ORs of diabetes comparing high ver­
sus low concentrations were 1.70 (95% CI: 
1.28, 2.27; I2 = 16.3%, pheterogeneity = 0.30) 
for total PCBs and 2.00 (95% CI: 1.13, 3.53; 
I 2 = 21.4%, pheterogeneity = 0.28) for HCB. 
Of note, estimates for HCB based on data 
from two previous studies (Lee et al. 2010, 
2011) and the NHL and breast cancer stud­
ies in the NHS. Most other POPs of interest 
showed positive associations, although none 
of these associations achieved statistical sig­
nificance. For example, the pooled ORs of 
diabetes for high versus low concentrations 
were 1.25 (95% CI: 0.94, 1.66; I2 = 36.8%, 
pheterogeneity = 0.16) for DDE, 1.20 (95% CI: 
0.73, 1.96; I2 = 24.7%, pheterogeneity = 0.26) 
for PCB­118, and 1.36 (95% CI: 0.69, 2.68; 
I2 = 0.0%, pheterogeneity = 0.38) for PCB­138 
(Figure 2). When we used a random­effects 
Table 2. Adjusted ORs (95% CIs) of incident diabetes according to the tertiles of lipid-standardized plasma POP concentrations (ng/g lipids) in 1990, the NHS.
Breast cancer study NHL study
POP Tertile 1 Tertile 2 Tertile 3 ptrend Tertile 1 Tertile 2 Tertile 3 ptrend
HCB
Median 19.5 29.8 44.2 27.5 37.0 51.5
Case/control 4/220 9/216 11/213 5/135 7/134 12/129
Model 1a 1.00 2.13 (0.60, 7.58) 3.73 (1.05, 13.3) 0.04 1.00 1.44 (0.40, 5.24) 3.46 (1.02, 11.7) 0.03
Model 2b 1.00 1.74 (0.47, 6.50) 2.76 (0.75, 10.1) 0.12 1.00 1.36 (0.36, 5.07) 3.52 (1.03, 12.1) 0.03
p,p´-DDE 
Median 349.5 773.6 1535.3 424.8 989.6 2099.5
Case/control 6/218 9/216 9/215 5/135 9/132 10/131
Model 1a 1.00 1.47 (0.48, 4.49) 1.59 (0.50, 5.03) 0.47 1.00 1.73 (0.54, 5.50) 1.57 (0.49, 5.07) 0.58
Model 2b 1.00 1.13 (0.35, 3.64) 1.32 (0.41, 4.27) 0.64 1.00 1.65 (0.51, 5.38) 1.79 (0.54, 5.86) 0.41
p,p´-DDT
Median 26.9 53.1 120.9 23.7 43.7 83.3
Case/control 7/217 8/217 9/215 7/133 7/134 10/131
Model 1a 1.00 1.11 (0.38, 3.25) 1.11 (0.38, 3.27) 0.87 1.00 0.81 (0.26, 2.49) 1.01 (0.34, 3.02) 0.90
Model 2b 1.00 1.17 (0.39, 3.54) 1.08 (0.36, 3.22) 0.94 1.00 0.75 (0.24, 2.40) 1.01 (0.34, 3.07) 0.86
PCB-118
Median 41.0 65.7 101.4 29.0 48.8 87.9
Case/control 6/218 9/216 9/215 6/134 7/134 11/130
Model 1a 1.00 1.50 (0.48, 4.63) 1.50 (0.48, 4.65) 0.53 1.00 1.18 (0.36, 3.92) 1.68 (0.51, 5.52) 0.37
Model 2b 1.00 1.34 (0.42, 4.27) 1.32 (0.42, 4.20) 0.68 1.00 1.16 (0.34, 3.93) 1.50 (0.45, 5.06) 0.49
PCB-138
Median 59.5 94.4 148.2 38.7 63.7 103.4
Case/control 9/215 6/219 9/215 6/134 11/130 7/134
Model 1a 1.00 0.74 (0.24, 2.26) 1.17 (0.42, 3.28) 0.70 1.00 1.40 (0.47, 4.16) 0.91 (0.28, 2.96) 0.76
Model 2b 1.00 0.69 (0.22, 2.16) 0.97 (0.33, 2.84) 0.96 1.00 1.40 (0.45, 4.32) 0.91 (0.27, 3.05) 0.75
PCB-153
Median 69.1 104.5 170.5 67.7 106.1 153.8
Case/control 8/216 6/219 10/214 7/133 11/130 6/135
Model 1a 1.00 0.87 (0.27, 2.80) 2.29 (0.77, 6.79) 0.09 1.00 1.22 (0.43, 3.50) 0.77 (0.23, 2.58) 0.64
Model 2b 1.00 0.85 (0.26, 2.78) 2.19 (0.72, 6.68) 0.12 1.00 1.26 (0.42, 3.78) 0.76 (0.22, 2.60) 0.61
PCB-180
Median 50.6 74.6 111.0 50.2 71.4 100.2
Case/control 8/216 9/216 7/217 9/131 10/131 5/136
Model 1a 1.00 1.75 (0.59, 5.16) 1.87 (0.57, 6.09) 0.32 1.00 1.11 (0.40, 3.09) 0.60 (0.17, 2.12) 0.42
Model 2b 1.00 1.66 (0.54, 5.08) 1.95 (0.57, 6.70) 0.31 1.00 1.13 (0.39, 3.23) 0.68 (0.19, 2.49) 0.55
∑PCBs (118,138,153,180)
Median 232.2 347.6 518.9 197.2 298.1 440.1
Case/control 10/214 4/221 10/214 5/135 13/128 6/135
Model 1a 1.00 0.49 (0.14, 1.67) 1.29 (0.47, 3.51) 0.53 1.00 1.91 (0.62, 5.87) 0.97 (0.27, 3.53) 0.76
Model 2b 1.00 0.40 (0.12, 1.41) 1.21 (0.43, 3.39) 0.59 1.00 2.26 (0.70, 7.27) 0.98 (0.26, 3.72) 0.72
Total PCBs
Median 521.9 742.6 1094.9 422.9 621.0 866.2
Case/control 8/216 7/218 9/215 7/133 10/131 7/134
Model 1a 1.00 1.08 (0.36, 3.25) 1.38 (0.47, 4.03) 0.54 1.00 1.10 (0.38, 3.22) 0.83 (0.25, 2.75) 0.74
Model 2b 1.00 1.21 (0.38, 3.80) 1.30 (0.43, 3.93) 0.65 1.00 1.25 (0.41, 3.80) 0.79 (0.23, 2.71) 0.65
Total POPs
Median 1054.9 1681.9 2702.5 1042.9 1779.2 2957.8
Case/control 8/216 7/218 9/215 5/135 13/128 6/135
Model 1a 1.00 1.57 (0.50, 4.96) 1.95 (0.62, 6.16) 0.27 1.00 1.32 (0.42, 4.12) 1.50 (0.49, 4.64) 0.50
Model 2b 1.00 1.31 (0.39, 4.37) 1.56 (0.48, 5.05) 0.47 1.00 1.19 (0.37, 3.87) 1.55 (0.49, 4.93) 0.45
ORs (95% CIs) were estimated using logistic regression. 
aModel 1: adjusted for age (years), smoking status (never/current smoker/past smoker), alcohol intake (0, 0.1–10, and > 10 g/day), physical activity (MET-hr/week), family history of 
 diabetes (yes/no), and baseline BMI in 1990. bModel 2: further adjusted for cancer case– control status.
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model to pool these data, we found similar 
results (data not shown). 
Meta­regression analysis indicated that 
the association between total PCBs and HCB 
and diabetes risk was not dependent on age, 
sex, other demographic variables, baseline 
total PCB or HCB concentrations, diabetes 
diagnosis strategies, duration of follow­up, or 
whether blood lipids were adjusted for in the 
final model (all p > 0.05, data not shown). 
The pooled OR of diabetes for total PCBs 
increased from 1.70 (95% CI: 1.28, 2.27) to 
2.05 (95% CI: 1.41, 2.98) after results from 
the Yucheng cohort were excluded (Wang et al. 
2008). Pooled data from our study and three 
previous investigations (Lee et al. 2011; Turyk 
et al. 2009; Vasiliu et al. 2006) did not support 
a nonlinear relationship between total PCB 
concentrations and diabetes (pnonlinearity = 0.99) 
[see Supplemental Material, Figure S1 (http://
dx.doi.org/10.1289/ehp.1205248)], although 
the power for detecting such a relationship 
was limited in the present analysis. Assuming 
a linear relationship, we estimated an OR of 
1.06 (95% CI: 1.02, 1.09) per nanogram per 
gram serum weight increase in total PCBs. We 
could not examine dose– response relations for 
 individual POPs because of  insufficient data.
Discussion
In this post hoc analysis using data from two 
prospective nested case– control studies among 
U.S. women, we found that plasma concentra­
tions of some POPs, particularly HCB, were 
associated with increased risk of developing 
T2D. This observation was supported by a 
meta­analysis of our data pooled with six other 
prospective studies that demonstrated positive 
overall associations for HCB and total PCB 
concentrations with incident diabetes. 
To our knowledge, this is the first prospec­
tive study to report a significant association 
between plasma HCB concentrations and 
risk of T2D. In a cross­sectional survey in a 
heavily polluted area of Eastern Slovakia, high 
HCB concentrations (> 1,364 vs. < 214 ng/g 
blood lipids) were significantly associated with 
pre diabetes prevalence, but not with diabetes 
prevalence (Ukropec et al. 2010). In contrast, 
HCB was significantly associated with diabetes 
status in cross­sectional studies among Koreans 
(Son et al. 2010) and Native Americans 
(Mohawk) (Codru et al. 2007). After pool­
ing our results with those from the Coronary 
Artery Risk Development in Young Adults 
(CARDIA) cohort (Lee et al. 2010) and the 
Prospective Investigation of the Vasculature 
in Uppsala Seniors study (Lee et al. 2011), we 
found a pooled RR of 2.0, comparing high 
with low HCB concentrations. The mecha­
nisms that may underlie our observations are 
largely unknown. HCB is a toxic chemical that 
has a long elimination half­life. Therefore, it 
has been used as a “model chemical” to predict 
the ultimate fate of other POPs (Barber et al. 
2005) and may only serve as a marker reflect­
ing long­term exposure of mixed POPs. In our 
study and previous reports (Lee et al. 2006), 
HCB was positively correlated with most other 
POPs considered. Therefore, it is difficult 
to attribute effects to HCB alone. Previous 
studies also documented significant correla­
tions between HCB and diabetes risk factors, 
including higher BMI (Lee et al. 2007a) and 
impaired fasting glucose (Langer et al. 2007), 
although plasma HCB was not significantly 
associated with BMI in our investigation in 
the NHS. More studies are needed to clarify 
potential mechanisms and establish the plausi­
bility of the epidemiological associations.
In comparison to HCB, there is bet­
ter evidence from animal experiments and 
human studies to support a causal role of 
PCBs and DDT in the etiology of T2D. An 
animal study showed that rats fed with fat 
rich in lipophilic POPs (primarily consist­
ing of DDT, DDE, and PCBs) developed 
abdominal obesity and insulin insensitivity 
(Ruzzin et al. 2010). In addition, each dou­
bling of PCB concentrations was associated 
with a 7% lower fasting insulin concentra­
tion in elderly Faroese residents with highly 
elevated PCB exposures from contaminated 
seafood (Grandjean et al. 2011). Moreover, 
high POP concentrations in  the human body 
were associated with impaired glucose tol­
erance in Greenland Inuit who had much 
higher POP exposures in comparison with the 
general population (Jørgensen et al. 2008), 
as well as among the U.S. population with 
Table 3. Pooled adjusted ORs (95% CIs) of incident diabetes according to the tertiles of lipid-standardized 
plasma POP concentrations (ng/g lipids), the NHS. 
Study-specific tertiles
POP 1 2 3 ptrend
HCB
Case/control 9/355 16/350 23/342
Model 1a 1.00 1.76 (0.71, 4.34) 3.59 (1.49, 8.64) 0.003
Model 2b 1.00 1.54 (0.61, 3.90) 3.14 (1.28, 7.67) 0.003
p,p´-DDE 
Case/control 11/353 18/348 19/346
Model 1a 1.00 1.59 (0.71, 3.55) 1.58 (0.69, 3.59) 0.39
Model 2b 1.00 1.36 (0.59, 3.13) 1.53 (0.66, 3.53) 0.31
p,p´-DDT
Case/control 14/350 15/351 19/346
Model 1a 1.00 0.95 (0.44, 2.07) 1.06 (0.49, 2.28) 0.84
Model 2b 1.00 0.95 (0.43, 2.11) 1.05 (0.48, 2.28) 0.90
PCB-118
Case/control 12/352 16/350 20/345
Model 1a 1.00 1.34 (0.59, 3.05) 1.58 (0.70, 3.59) 0.28
Model 2b 1.00 1.25 (0.54, 2.90) 1.41 (0.61, 3.25) 0.43
PCB-138
Case/control 15/349 17/349 16/349
Model 1a 1.00 1.02 (0.47, 2.24) 1.05 (0.48, 2.28) 0.89
Model 2b 1.00 0.99 (0.44, 2.20) 0.94 (0.42, 2.11) 0.89
PCB-153
Case/control 15/349 17/349 16/349
Model 1a 1.00 1.05 (0.48, 2.29) 1.41 (0.63, 3.15) 0.32
Model 2b 1.00 1.05 (0.47, 2.35) 1.36 (0.59, 3.10) 0.47
PCB-180
Case/control 17/347 19/347 12/353
Model 1a 1.00 1.38 (0.66, 2.89) 1.10 (0.46, 2.61) 0.76
Model 2b 1.00 1.35 (0.63, 2.91) 1.18 (0.48, 2.89) 0.71
∑PCBs (118,138,153,180)
Case/control 15/349 17/349 16/349
Model 1a 1.00 1.02 (0.45, 2.34) 1.16 (0.52, 2.55) 0.76
Model 2b 1.00 1.01 (0.43, 2.38) 1.12 (0.49, 2.53) 0.79
Total PCBs
Case/control 15/349 17/349 16/349
Model 1a 1.00 1.09 (0.51, 2.35) 1.10 (0.50, 2.45) 0.76
Model 2b 1.00 1.23 (0.55, 2.73) 1.04 (0.46, 2.38) 0.92
Total POPs
Case/control 15/349 17/349 16/349
Model 1a 1.00 1.43 (0.64, 3.23) 1.71 (0.76, 3.82) 0.22
Model 2b 1.00 1.25 (0.54, 2.90) 1.55 (0.68, 3.54) 0.30
Data were pooled ORs (95% CIs) of the estimates of the NHL and breast cancer studies, using a fixed-effects model. 
To derive pooled ptrend values, we pooled regression coefficients for the median concentrations of POP tertiles using a 
fixed-effects model and then estimated p-values for the pooled regression coefficients. 
aModel 1: adjusted for age (years), smoking status (never/current smoker/past smoker), alcohol intake (0, 0.1–10, and 
> 10 g/day), physical activity (MET-hr/week), family history of diabetes (yes/no), and baseline BMI in 1990. bModel 2: 
further adjusted for cancer case– control status. 
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background POP exposure levels (Lee et al. 
2007a). Animal studies have shown that 
some other polychlorinated compounds, 
such as 2,3,7,8­tetrachlorodibenzo­p­dioxin 
and 1,2,3,4,7,8­hexachlorodibenzo­p­ dioxin, 
may impair glucose metabolism and regu­
lation by reducing glucose uptake (Enan 
and Matsumura 1994) or by inhibiting the 
expression of insulin­ like growth factor 1 
and its binding protein (Croutch et al. 2005; 
Olsen et al. 1994). Despite this evidence, only 
a small number of prospective human studies 
Table 4. Characteristics of prospective studies regarding exposure levels of POPs in relation to incident diabetes.
Reference Study participants
Exposure and assay 
method
Outcome and 
ascertainment Comparison categories RR (95% CI)
Covariates in the 
fully adjusted model
Prospective cohort studies
Vasiliu et al. 
2006 
The Michigan polybrominated 
biphenyl (PBB) cohort (USA) 
Total n: 1,384 
Female: 50.3% 
Age: ≥ 20 years 
Follow-up: 25 years
Serum PBBs and PCBs 
measured using gas 
chromatography
Incident diabetes cases: 
total n = 180 (89 men 
and 91 women); 
diabetes was identified 
by self-report
For serum PCBs: highest 
(> 10 ppb) vs. lowest 
(≤ 5 ppb) group for men 
and women
Men: 1.74 (0.91, 3.34)
Women: 2.33 
(1.25, 4.34) 
Age, BMI, smoking, 
alcohol consumption 
at enrollment, 
and serum PBB 
concentrations
Wang et al. 
2008 
The Yucheng cohort (Taiwan, 
China) 
Total n: 378 
Yucheng subjects poisoned 
through ingesting PCB-
contaminated oil in 
1978–1979 and 370 matched 
reference subjects with 
background- level exposures 
Female: 59.0% 
Age: > 30 years 
Follow-up: 24 years
Serum concentrations of 
a mixture of 33 PCBs 
measured using gas 
chromatography
Incident T2D cases: 
total n = 81 (44 men 
and 37 women); T2D 
was identified through 
self-report
Yucheng vs. reference 
group; mean ± SD of 
serum PCBs (ppb) were 
73.3 ± 86.3 for male 
Yucheng participants, 
and 87.4 ± 151.0 
for female Yucheng 
participants, and the 
mean of total PCBs in 
the reference group 
was 1.67.
Men: 1.0 (0.5, 1.9)
Women: 2.1 (1.1, 4.5)
Age and BMI for 
women; age, BMI, 
cigarette smoking, 
and alcohol drinking 
for men
Lee et al. 2011 The Prospective Investigation 
of the Vasculature in 
Uppsala Seniors (PIVUS) 
study (Sweden) 
Total n: 725 
Female: 51.7% 
Age: 70 years 
Follow-up: 5 years
Plasma concentrations 
of 19 POPs (14 PCBs, 
3 organochlorine 
pesticides, 
1 brominated diphenyl 
ether, and 1 dioxin) 
measured using 
high-resolution 
chromatography 
coupled with high-
resolution mass 
spectrometry
Incident T2D cases: 
total n = 36; T2D 
was identified as a 
fasting blood glucose 
≥ 6.2 mmol/L or self-
report of use of insulin 
or oral hypoglycemic 
agents
Highest vs. lowest 
quintile of POP 
concentrations 
(pg/g wet weight); 
PCB-118: 309–1,637 vs. 
25.0–125; 
PCB-138: 1,206–2,739 vs. 
107–563; 
PCB-153: 1,957–4,672 vs. 
117–1,007; 
PCB-180: 1,585–7,865 vs. 
153–858; 
DDE: 4,040–23,271 vs. 
11.0–902; 
HCB: 370–4,252 vs. 
88.0–173; 
ΣPCBs: not available
3.6 (0.7, 18.8) for PCB-118; 
3.2 (0.8, 13.2) for PCB-138; 
1.7 (0.5, 6.2) for PCB-153; 
4.8 (1.1, 20.9) for PCB-180; 
2.1 (0.7, 6.3) for DDE;
2.1 (0.6, 7.1) for HCB;
7.5 (1.4, 38.8) for ΣPCBs
Sex, BMI, cigarette 
smoking, alcohol 
consumption, 
exercise, 
triglycerides, and 
total cholesterol
Turyk et al. 
2009 
The Great Lakes Consortium 
for the Health Assessment 
of Great Lakes Sport Fish 
Consumption (USA) 
Total n: 471 
Female: 40.8% 
Age: mean = 52.2 and 
47.9 years for diabetes 
and nondiabetes subjects, 
respectively 
Follow-up: 11 years
Serum concentrations 
of DDE, PCB-118, and 
ΣPCBs (sum of PCB 
congeners 74, 99, 118, 
146, 180, 194, 201, 
206, 132/153, 138/163, 
170/190, 182/187, and 
196/20) measured using 
gas chromatography
Incidence diabetes 
cases: total n = 36; 
diabetes was 
identified by self-
report 
Highest vs. lowest tertile 
of POP concentrations 
(ng/g wet weight); 
DDE: 5.4–49.2 vs. < LOD 
to 2.2; 
ΣPCBs: 4.3–29.8 vs. 
< LOD to 1.6; 
PCB-118: 0.3–4.6 vs. 
< LOD to 0.1
7.1 (1.6, 31.9) for DDE;
1.8 (0.6, 5.0) for ΣPCBs;
1.3 (0.5, 3.0) for PCB-118
Age, age squared, 
BMI, sex, serum 
lipids, smoking, 
alcohol use, all fish 
meals in the last 
year, and Great 
Lakes sport-caught 
fish meals in the 
last year
Case– control studies 
Rignell-Hydbom 
et al. 2009 
The Women’s Health In the 
Lund Area cohort study 
(Sweden) 
Total n: 742 (371 cases and 
371 controls) 
Female: 100% 
Age: 50–59 years 
Follow-up: 11 years
Serum concentrations 
of PCB-153 and DDE 
measured using 
high-resolution mass 
spectrometry
Incident T2D cases: 
total n = 371; T2D was 
identified by linkage 
with the Swedish 
inpatient and out-
patient registers
Highest vs. the other 
three lower quartiles 
combined; 
PCB-153: > 1,790 pg/mL 
vs. ≤ 1,790 pg/mL; 
DDE: > 4,600 pg/mL vs. 
≤ 4,600 pg/mL
0.99 (0.71, 1.4) for 
PCB-153; 
1.1 (0.76, 1.5) for DDE
None
Lee et al. 2010 The Coronary Artery Risk 
Development in Young 
Adults (CARDIA) cohort study 
(USA);
Total n: 180 (90 cases and 
90 controls)
Female: 46.6% 
Age: 18–30 years
Follow-up: 18 years
Serum concentrations 
of 31 POPs 
(8 organochlorine 
pesticides, 22 PCBs, 
and 1 PBB congener) 
measured using gas 
chromatography isotope 
dilution high-resolution 
mass spectrometry
Incident T2D cases: 
total n = 90; diabetes 
was defined as 
ever having taken 
antidiabetic 
medications or ever 
having had fasting 
glucose ≥ 126 mg/dL 
at ≥ 2 examinations
Highest vs. lowest 
quartile of POP 
concentrations 
(pg/g wet weight); 
HCB: not available; 
DDE: > 5,731 vs. ≤ 2,153; 
DDT: not available; 
PCB-118: not available; 
PCB-153: > 466 vs. ≤ 204; 
PCB-180: not available
1.0 (0.4, 2.6) for HCB;
0.7 (0.2, 1.9) for DDE;
0.9 (0.3, 2.6) for DDT;
0.5 (0.2, 1.4) for PCB-118; 
0.8 (0.2, 2.6) for PCB-153; 
1.1 (0.3, 3.9) for PCB-180
Age, sex, race, BMI, 
triglycerides, and 
total cholesterol
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have been conducted to investigate the asso­
ciation of PCBs, DDT, and DDE with dia­
betes. In a prospective study among Great 
Lakes sport fish consumers, higher DDE con­
centrations, but not total PCBs, were signifi­
cantly associated with risk of diabetes (Turyk 
et al. 2009). Similarly, Rignell­Hydbom et al. 
(2009) found that DDE, but not PCB­153, 
showed a significant relationship with T2D in 
a case– control study among Swedish women, 
although the relationship was only evident 
among cases diagnosed ≥ 7 years after base­
line. More recently, among a Swedish elderly 
population, Lee et al. (2011) documented 
that PCB­138, total PCBs, and summed val­
ues of DDE, trans­nonachlor, and HCB, were 
significantly associated with incident T2D. 
Inconsistencies between studies may be par­
tially explained by differences in age, sex, or 
other characteristics and differences in POP 
exposure distributions among study popula­
tions. More important, most of these studies 
were based on small samples. In our meta­
analysis, after we pooled all existing data, we 
observed a significant RR of 1.70 comparing 
high to low total PCB concentrations. All of 
these POPs have long elimination half­lives 
and they can still be detected among the U.S. 
population despite the fact that the use of 
these chemicals has been banned since the 
1970s (Lee et al. 2010). Our findings suggest 
that past accumulation and continued expo­
sure of these persistent pollutants may be a 
potent risk factor for developing diabetes. 
The major strengths of our study included 
a prospective study design, a long follow­
 up of 18 years for the analysis of NHS data, 
and the use of meta­analysis to combine 
the NHS estimates with data from previous 
studies. There are several limitations of this 
study as well. First, we explored the associa­
tion between POP concentrations and incident 
diabetes using existing data from two cancer 
case– control studies in the NHS. Because these 
studies were not designed to evaluate diabetes 
risk and because our participants were female 
registered nurses who were primarily white, 
results generated from these participants may 
have restricted generalizability, even within the 
entire NHS cohort. Further, we only accumu­
lated a small number of diabetes cases from 
these two studies, resulting in limited statisti­
cal power. Second, the POP concentrations 
were measured by different methods in the two 
studies. However, we conducted study­specific 
analy ses to account for between­study varia­
tion, and when we used a standardized score 
that minimized this between­study variation in 
a sensitivity analysis, we observed largely simi­
lar results. Third, the studies included in the 
meta­analysis measured various, inter correlated 
individual POPs with different concentrations. 
We cannot exclude the possibility that the sig­
nificant associations observed for HCB and 
total PCBs may be actually due to the effects 
of individual PCB congeners or other POPs. 
Fourth, we have limited statistical power for 
testing any nonlinear relationship between total 
PCBs and risk of diabetes in this meta­analysis. 
In addition, the dose– response relationship for 
individual POPs may be at least partly driven 
by individual or joint effects of POPs, which 
may vary depending on the concentrations of 
the individual POPs involved. Lee et al. (2010) 
found inverted U­shaped associations of diabe­
tes with a summary measure of 31 POPs, and 
with certain individual PCB congeners, in the 
CARDIA study. Like that of other endocrine 
disruptors, the relationship between POPs and 
diabetes risk may depend on the level of expo­
sure, i.e., POPs might increase diabetes risk 
monotonically at low dose, whereas at higher 
doses the effects of POPs may plateau or even 
decline (Daston et al. 2003; Welshons et al. 
2003). Clearly, more evidence is needed to 
shed light on this complex dose– response 
relationship. Fifth, although tests of hetero­
geneity were far from significant, the power 
to detect heterogeneity was low, and the stud­
ies included in the meta­analysis differed with 
regard to age, sex, race, diabetes ascertainment 
or classification, and other characteristics that 
Figure 2. Pooled fixed-effects ORs (95% CIs) of incident diabetes comparing extreme categories (the 
highest vs. the lowest) of POP concentrations; p-values are pheterogeneity.
10.5 2 3
Study OR (95% CI)
Total PCBs
Vasiliu et al. 2006 (men)
Vasiliu et al. 2006 (women)
Wang et al. 2008 (men)
Wang et al. 2008 (women)
Turyk et al. 2009
Lee et al. 2011
NHS (breast cancer)
NHS (NHL)
Subtotal (I 2 = 16.3%, p = 0.302)
p,p´ -DDE
Rignell-Hydbom et al. 2009
Turyk et al. 2009
Lee et al. 2010
Lee et al. 2011
NHS (breast cancer)
NHS (NHL)
Subtotal (I 2 = 36.8%, p = 0.161)
p,p´ -DDT
Lee et al. 2010
NHS (breast cancer)
NHS (NHL)
Subtotal (I 2 = 0.0%, p = 0.964)
HCB
Lee et al. 2010
Lee et al. 2011
NHS (breast cancer)
NHS (NHL)
Subtotal (I 2 = 21.4%, p = 0.282)
PCB-118
Turyk et al. 2009
Lee et al. 2010
Lee et al. 2011
NHS (breast cancer)
NHS (NHL)
Subtotal (I 2 = 24.7%, p = 0.257)
PCB-138
Lee et al. 2011
NHS (breast cancer)
NHS (NHL)
Subtotal (I 2 = 0.0%, p = 0.375)
PCB-153
Rignell-Hydbom et al. 2009
Lee et al. 2010
Lee et al. 2011
NHS (breast cancer)
NHS (NHL)
Subtotal (I 2 = 0.0%, p = 0.546)
PCB-180
Lee et al. 2010
Lee et al. 2011
NHS (breast cancer)
NHS (NHL)
Subtotal (I 2 = 37.2%, p = 0.189)
1.74 (0.91, 3.33)
2.33 (1.25, 4.34)
1.00 (0.51, 1.95)
2.10 (1.04, 4.25)
1.80 (0.62, 5.20)
7.50 (1.42, 39.48)
1.38 (0.47, 4.04)
0.83 (0.25, 2.75)
1.70 (1.28, 2.27)
1.10 (0.78, 1.55)
7.10 (1.59, 31.70)
0.70 (0.23, 2.16)
2.10 (0.70, 6.30)
1.59 (0.50, 5.04)
1.57 (0.49, 5.05)
1.25 (0.94, 1.66)
0.90 (0.31, 2.65)
1.11 (0.38, 3.26)
1.01 (0.34, 3.01)
1.00 (0.54, 1.87)
1.00 (0.39, 2.55)
2.10 (0.61, 7.22)
3.73 (1.05, 13.27)
3.46 (1.02, 11.71)
2.00 (1.13, 3.53)
1.30 (0.53, 3.18)
0.50 (0.19, 1.32)
3.60 (0.69, 18.66)
1.50 (0.48, 4.67)
1.68 (0.51, 5.53)
1.20 (0.73, 1.96)
3.20 (0.79, 13.00)
1.17 (0.42, 3.27)
0.91 (0.28, 2.96)
1.36 (0.69, 2.68)
0.99 (0.71, 1.39)
0.80 (0.22, 2.88)
1.70 (0.48, 5.99)
2.29 (0.77, 6.80)
0.77 (0.23, 2.58)
1.06 (0.79, 1.42)
1.10 (0.31, 3.97)
4.80 (1.10, 20.92)
1.87 (0.57, 6.11)
0.60 (0.17, 2.12)
1.46 (0.77, 2.77)
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may modify the associations of interest. Sixth 
and last, although we observed significant asso­
ciations for HCB and total PCBs with diabe­
tes risk in the meta­analysis, we cannot rule 
out the possibility that these associations may 
have been due to other POPs, other unmea­
sured chemicals, residual confounding or other 
sources of bias, or chance. Moreover, the asso­
ciation between HCB and diabetes has been 
evaluated in only two prior prospective studies. 
More prospective studies with larger sample 
size and long follow­up duration are needed, 
and such studies should include HCB to con­
firm or refute the findings in this meta­ analysis.
Conclusions
Our estimates based on two prospective stud­
ies and a meta­analysis indicate that higher 
plasma HCB and total PCB concentrations 
are significantly associated with incident T2D. 
These findings support a positive association 
between POP exposure and risk of T2D.
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